[1] GUO YY,SUI CH,LUO QQ,et al. Dynamic fluctuation of blood glucose and its effects on prognosis in patients with nonalcoholic fatty liver disease complicated with type 2 diabetes mellitus[J]. J Clin Exp Med,2019,18(11):1173-1175.(in Chinese)郭郁郁,隋春华,罗清琼,等.非酒精性脂肪性肝病合并2型糖尿病患者血糖动态波动水平及其对预后的影响[J].临床和实验医学杂志,2019,18(11):1173-1175.
|
[2] LI AA,AHMED A,KIM D. Extrahepatic manifestations of nonalcoholic fatty liver disease[J]. Gut Liver,2019.[Epub ahead of print]
|
[3] ZHOU F,ZHOU J,WANG W,et al. Unexpected rapid increase in the burden of nonalcoholic fatty liver disease in china from 2008 to 2018:A systematic review and Meta-analysis[J]. Hepatology,2019,26(4):972-976.
|
[4] ALLEN AM,HICKS SB,MARA KC,et al. The risk of incident extrahepatic cancers is higher in nonalcoholic fatty liver disease than obesity-a longitudinal cohort study[J]. J Hepatol,2019,26(4):698-703.
|
[5] LI JX,CHEN J,WANG YL. Consensus on the diagnosis and treatment of non-alcoholic fatty liver diseases based on integrated Chinese and western medicine(2017)[J]. Chin J Integr Trad West Med Dig,2017,25(11):805-811.(in Chinese)李军祥,陈誩,王允亮.非酒精性脂肪性肝病中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2017,25(11):805-811.
|
[6] WU JY,ZHENG L,MO JF,et al. Regulation of N-acetylcysteine on peripheral circulatory and hepatic myeloid-derived suppressor cells in non-alcoholic fatty liver disease mice[J]. Chin J Clin Pharmacol Ther,2019,24(9):989-996.(in Chinese)吴加元,郑丽,莫娟芬,等.N-乙酰半胱氨酸调控非酒精性脂肪性肝病小鼠外周循环及肝脏局部髓源抑制细胞的研究[J].中国临床药理学与治疗学,2019,24(9):989-996.
|
[7] PEVERILL W,POWELL L,SKOIEN R. Evolving concepts in the pathogenesis of NASH:Beyond steatosis and inflammation[J]. Int J Mol Sci,2014,15(5):8591-8638.
|
[8] HASAN JANI ROUSHAN MR,HAJIAHMADI M,SHAFAIE S.Histopathological features of liver and its relation to serum transaminase levels in 91 cases of anti-HBe-positive chronic hepatitis B[J]. Int J Clin Pract,2005,59(7):791-794.
|
[9] SUI L. Application and evaluation of serum AFU,LAP and GGT in the diagnosis of early primary liver cancer[J]. Chin J Lab Diag,2016,20(7):1088-1089.(in Chinese)隋菱.血清AFU、LAP和GGT联合检测在早期原发性肝癌诊断中的应用与评价[J].中国实验诊断学,2016,20(7):1088-1089.
|
[10] GAO HF,ZHAO QJ,WANG J. Application of serum alphafetoprotein,alpha-l-fucosidase,5'-nucleotide enzyme and gamma-glutamyl transpeptidase in early diagnosis of hepatocellular carcinoma[J]. Cancer Res Clin,2016,28(8):519-522.(in Chinese)高海锋,赵秋剑,王静,等.血清甲胎蛋白、α-L-岩藻糖苷酶、5'-核苷酸酶和γ-谷氨酰转肽酶在肝细胞癌早期诊断中的应用[J].肿瘤研究与临床,2016,28(8):519-522.
|
[11] TANAKA N,KIMURA T,FUJIMORI N,et al. Current status,problems,and perspectives of non-alcoholic fatty liver disease research[J]. World J Gastroenterol,2019,25(2):163-177.
|
[12] PARK H,DAWWAS GK,LIU X,et al. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease:A propensity-matched cohort study[J]. J Intern Med,2019,286(6):711-722.
|
[13] KAYSEN GA. New insights into lipid metabolism in chronic kidney disease:What are the practical implications?[J]. Blood Purif,2009,27(1):86-91.
|
[14] FUNK J,OTT V,HERRMANN A,et al. Semiautomated quantitative image analysis of glomerular immunohistochemistry markers desmin,vimentin,podocin,synaptopodin and WT-1in acute and chronic rat kidney disease models[J]. Histochem Cell Biol,2016,145(3):315-326.
|
[15] WELSH GI,HALE LJ,EREMINA V,et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function[J]. Cell Metabolism,2010,12(4):329-340.
|
[16] IRSIK DL,CHEN JK,BRANDS MW. Chronic renal artery insulin infusion increases mean arterial pressure in male Sprague Dawley rats[J]. Am J Physiol Renal Physiol,2017,14(3):374-378.
|
[17] SALEEM MA. The human glomerular podocyte is a novel target for insulin action[J]. Diabetes,2005,54(11):3095-3102.
|
[18] FUKUI H,HORI M,FUKUDA Y,et al. Evaluation of fatty pancreas by proton density fat fraction using 3-T magnetic resonance imaging and its association with pancreatic cancer[J].Eur J Radiol,2019,118:25-31.
|
[19] DELLA CORTE C,MOSCA A,MAJO F,et al. Nonalcoholic fatty pancreas disease and nonalcoholic fatty liver disease:More than ectopic fat[J]. Clin Endocrinol(Oxf),2015,83(5):656-662.
|
[20] YUAN BB,TAN YE,LIU JJ,et al. Current status of the research on nonalcoholic fatty pancreatic disease[J]. J Clin Hepatol,2019,35(5):1161-1164.(in Chinese)袁贝贝,谭玉娥,刘京京,等.非酒精性脂肪性胰腺病的研究现状[J].临床肝胆病杂志,2019,35(5):1161-1164.
|
[21] WANG CY,OU HY,CHEN MF,et al. Enigmatic ectopic fat:Prevalence of nonalcoholic fatty pancreas disease and its associated factors in a chinese population[J]. J Am Heart Assoc,2014,3(1):e297-e303.
|
[22] OU HY,WANG CY,YANG YC,et al. The association between nonalcoholic fatty pancreas disease and diabetes[J].PLo S One,2013,8(5):e62561.
|
[23] CHEN D,LIESS C,POLJAK A,et al. Phenotypic characterization of insulin-resistant and insulin-sensitive obesity[J].J Clin Endocrinol Metab,2015,100(11):4082-4091.
|
[24] TUSHUIZEN ME,BUNCK MC,POUWELS PJ,et al. Pancreatic fat content and beta-cell function in men with and without type 2diabetes[J]. Diabetes Care,2007,30(11):2916-2921.
|